SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 151 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $2,490,000 | +63.3% | 226,335 | +45.4% | 0.00% | +100.0% |
Q1 2017 | $1,525,000 | +21.5% | 155,623 | +33.9% | 0.00% | 0.0% |
Q4 2016 | $1,255,000 | -45.1% | 116,217 | -47.8% | 0.00% | -50.0% |
Q3 2016 | $2,284,000 | -42.7% | 222,827 | -25.2% | 0.00% | -42.9% |
Q2 2016 | $3,987,000 | -31.9% | 298,014 | -35.2% | 0.01% | -36.4% |
Q1 2016 | $5,855,000 | +31.2% | 459,607 | -5.2% | 0.01% | +22.2% |
Q4 2015 | $4,461,000 | +61.3% | 484,848 | +21.7% | 0.01% | +50.0% |
Q3 2015 | $2,765,000 | – | 398,426 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athos Capital Ltd | 284,200 | $3,126,000 | 1.80% |
Nine Chapters Capital Management LLC | 13,600 | $150,000 | 1.42% |
Stonepine Capital Management, LLC | 216,307 | $2,379,000 | 1.28% |
GLG Partners LP | 1,588,897 | $17,478,000 | 0.97% |
MENTA CAPITAL LLC | 431,996 | $4,752,000 | 0.56% |
Sapphire Star Partners LP | 24,834 | $273,000 | 0.34% |
Yakira Capital Management, Inc. | 85,500 | $941,000 | 0.28% |
TFS CAPITAL LLC | 55,104 | $606,000 | 0.24% |
BRANT POINT INVESTMENT MANAGEMENT LLC | 100,000 | $1,100,000 | 0.13% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 102,261 | $1,125,000 | 0.12% |